ApeX Protocol vs Mira — how do they compare? ApeX Protocol trades at Rp3,359 (market cap Rp499,75M, Rp21,75M 24h volume), while Mira trades at Rp698.2 (market cap Rp224,51M, Rp102,44M 24h volume). The key difference: ApeX Protocol is far larger — about 2.2× Mira's market cap, and ApeX Protocol's circulating supply is 146,2M / 500M APEX (30%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold ApeX Protocol for 20 Days and Mira for 22 Days on average.
| APEX | MIRA | |
|---|---|---|
Market Cap | Rp499,75M | Rp224,51M |
Volume (24h) | Rp21,75M | Rp102,44M |
Circulating Supply | 146,2M / 500M APEX (30%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 20 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
ApeX Protocol (APEX) is trading at Rp3,742 with a market cap of Rp547.43 million, showing a bearish technical signal overall. The asset is near support at S1 (Rp3,648) with RSI_6 at 27.48 indicating potential oversold conditions. Only 30% of the max supply (500 million APEX) is in circulation, with an average hold time of 20 days. Recent news from GlobeNewsWire (2026-06-18) discusses survey results but is unrelated to the token's protocol or ecosystem developments.
Overall outlook remains cautious due to bearish momentum and limited fundamental catalysts. Key opportunities include oversold RSI levels for potential short-term rebounds, while major risks involve low liquidity, high volatility, and lack of recent protocol updates. Investors should monitor support levels closely for any breakdown or reversal signals.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
ApeX Protocol is a decentralized, non-custodial, permissionless, and censorship-resistant perpetual derivatives protocol. It facilitates the creation of perpetual swap markets for any token pairs. Users can engage in crypto derivatives trading on the Ethereum blockchain without intermediaries, while retaining complete control over their private keys.
Read more on APEX →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →